Stimulation of human T cells with sulfonamides and sulfonamide metabolites

Journal of Allergy and Clinical Immunology

Volumn 125, Issue 2, 2010, Pages

  Castrejon, J Luis ^a   Berry, Neil ^a   El Ghaiesh, Sabah ^a   Gerber, Basil ^b   Pichler, Werner J ^b   Park, B Kevin ^a   Naisbitt, Dean J ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

drug hypersensitivity; drug metabolism; Human; T cells

Indexed keywords

HAPTEN; HYDROXYLAMINE; NITROSOBENZENE; SULFADIAZINE; SULFAMETHOXAZOLE; SULFAPYRIDINE;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; ATOM; CASE REPORT; CELL CLONING; CELL PROLIFERATION; CROSS REACTION; EOSINOPHILIA; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; LYMPHOCYTE; MOLECULE; PHARMACOPHORE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RASH; STEVENS JOHNSON SYNDROME; T LYMPHOCYTE; URINARY TRACT INFECTION;

EID: 75849160138     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.10.031     Document Type: Article

References (38)

1. Bigby M., Jick S., Jick H., and Arndt K. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 256 (1986) 3358-3363
2. Masters P.A., O'Bryan T.A., Zurlo J., Miller D.Q., and Joshi N. Trimethoprim-sulfamethoxazole revisited. Arch Intern Med 163 (2003) 402-410
3. Alfirevic A., Vilar F.J., Alsbou M., Jawaid A., Thomson W., Ollier W.E., et al. TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole. Pharmacogenomics 10 (2009) 531-540
4. Depta J.P., Altznauer F., Gamerdinger K., Burkhart C., Weltzien H.U., and Pichler W.J. Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity. J Allergy Clin Immunol 113 (2004) 519-527
5. Burkhart C., von Greyerz S., Depta J.P., Naisbitt D.J., Britschgi M., Park K.B., et al. Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells. Br J Pharmacol 132 (2001) 623-630
6. Schnyder B., Burkhart C., Schnyder-Frutig K., von Greyerz S., Naisbitt D.J., Pirmohamed M., et al. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals. J Immunol 164 (2000) 6647-6654
7. von Greyerz S., Zanni M.P., Frutig K., Schnyder B., Burkhart C., and Pichler W.J. Interaction of sulfonamide derivatives with the TCR of sulfamethoxazole-specific human alpha beta+ T cell clones. J Immunol 162 (1999) 595-602
8. Schnyder B., Frutig K., Mauri-Hellweg D., Limat A., Yawalkar N., and Pichler W.J. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazole-induced skin reaction. Clin Exp Allergy 28 (1998) 1412-1417
9. Schnyder B., Mauri-Hellweg D., Zanni M., Bettens F., and Pichler W.J. Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J Clin Invest 100 (1997) 136-141
10. Farrell J., Naisbitt D.J., Drummond N.S., Depta J.P., Vilar F.J., Pirmohamed M., et al. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans. J Pharmacol Exp Ther 306 (2003) 229-237
11. Nassif A., Bensussan A., Dorothee G., Mami-Chouaib F., Bachot N., Bagot M., et al. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol 118 (2002) 728-733
12. Mauri-Hellweg D., Bettens F., Mauri D., Brander C., Hunziker T., and Pichler W.J. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 155 (1995) 462-472
13. Pichler W.J. Delayed drug hypersensitivity reactions. Ann Intern Med 139 (2003) 683-693
14. Landsteiner K., and Jacobs J. Studies on the sensitization of animals with simple chemical compounds. J Exp Med 61 (1935) 643-656
15. Park B.K., Pirmohamed M., and Kitteringham N.R. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem Res Toxicol 11 (1998) 969-988
16. Cribb A.E., and Spielberg S.P. Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther 51 (1992) 522-526
17. Gill H.J., Hough S.J., Naisbitt D.J., Maggs J.L., Kitteringham N.R., Pirmohamed M., et al. The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat. J Pharmacol Exp Ther 282 (1997) 795-801
18. Callan H.E., Jenkins R.E., Maggs J.L., Lavergne S.N., Clarke S.E., Naisbitt D.J., et al. Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation. Chem Res Toxicol 22 (2009) 937-948
19. Cheng L., Stewart B.J., You Q., Petersen D.R., Ware J.A., Piccotti J.R., et al. Covalent binding of the nitroso metabolite of sulfamethoxazole is important in induction of drug-specific T-cell responses in vivo. Mol Pharmacol 73 (2008) 1769-1775
20. Naisbitt D.J., Farrell J., Gordon S.F., Maggs J.L., Burkhart C., Pichler W.J., et al. Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation. Mol Pharmacol 62 (2002) 628-637
21. Manchanda T., Hess D., Dale L., Ferguson S.G., and Rieder M.J. Haptenation of sulfonamide reactive metabolites to cellular proteins. Mol Pharmacol 62 (2002) 1011-1026
22. Naisbitt D.J., Hough S.J., Gill H.J., Pirmohamed M., Kitteringham N.R., and Park B.K. Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity. Br J Pharmacol 126 (1999) 1393-1407
23. Naisbitt D.J., O'Neill P.M., Pirmohamed M., and Park B.K. Synthesis and reactions of nitroso sulfamethoxazole with biological nucleophiles-implications for immune-mediated toxicity. Bioorg Med Chem Let 6 (1996) 1511-1516
24. Summan M., and Cribb A.E. Novel non-labile covalent binding of sulfamethoxazole reactive metabolites to cultured human lymphoid cells. Chem Biol Interact 142 (2002) 155-173
25. Sanderson J.P., Naisbitt D.J., Farrell J., Ashby C.A., Tucker M.J., Rieder M.J., et al. Sulfamethoxazole and its metabolite nitroso sulfamethoxazole stimulate dendritic cell costimulatory signaling. J Immunol 178 (2007) 5533-5542
26. Hopkins J.E., Naisbitt D.J., Humphreys N., Dearman R.J., Kimber I., and Park B.K. Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells. Toxicology 206 (2005) 221-231
27. Naisbitt D.J., Gordon S.F., Pirmohamed M., Burkhart C., Cribb A.E., Pichler W.J., et al. Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo. Br J Pharmacol 133 (2001) 295-305
28. Choquet-Kastylevsky G., Santolaria N., Tedone R., Aujoulat M., and Descotes J. Induction of delayed-type hypersensitivity to sulfamethoxazole in mice: role of metabolites. Toxicol Lett 119 (2001) 183-192
29. Nassif A., Bensussan A., Boumsell L., Deniaud A., Moslehi H., Wolkenstein P., et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 114 (2004) 1209-1215
30. Nyfeler B., and Pichler W.J. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 27 (1997) 175-181
31. Wu Y., Sanderson J.P., Farrell J., Drummond N.S., Hanson A., Bowkett E., et al. Activation of T cells by carbamazepine and carbamazepine metabolites. J Allergy Clin Immunol 118 (2006) 233-241
32. Pirmohamed M., James S., Meakin S., Green C., Scott A.K., Walley T.J., et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329 (2004) 15-19
33. Gruchalla R.S., and Pirmohamed M. Clinical practice. Antibiotic allergy. N Engl J Med 354 (2006) 601-609
34. Naisbitt D.J., Pirmohamed M., and Park B.K. Drug presentation to T cells. J Allergy Clin Immunol 115 (2005) 876-878
35. Di Girolamo F., Campanella L., Samperi R., and Bachi A. Mass spectrometric identification of hemoglobin modifications induced by nitrosobenzene. Ecotoxicol Environ Saf 72 (2009) 1601-1608
36. Moulon C., Choleva Y., Thierse H.J., Wild D., and Weltzien H.U. T cell receptor transfection shows non-HLA-restricted recognition of nickel by CD8+ human T cells to be mediated by alphabeta T cell receptors. J Invest Dermatol 121 (2003) 496-501
37. Gamerdinger K., Moulon C., Karp D.R., Van Bergen J., Koning F., Wild D., et al. A new type of metal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel. J Exp Med 197 (2003) 1345-1353
38. Lu L., Vollmer J., Moulon C., Weltzien H.U., Marrack P., and Kappler J. Components of the ligand for a Ni++ reactive human T cell clone. J Exp Med 197 (2003) 567-574